Review began 08/26/2022 review ended 09/14/2022 published 09/20/2022 © copyright

HIGHLIGHTS

• who: Actinium-PSMA as Emerging Theranostic and collaborators from the Medical College Teaching Hospital, Kathmandu, NPL Department of Internal Medicine, Manipal College of Medical Cardiology, Memorial Healthcare System, Pembroke Pines, USA have published the paper: Review began 08/26/2022 Review ended 09/14/2022 Published 09/20/2022 u00a9 Copyright, in the Journal: (JOURNAL)
• what: The discovery of various PSMA ligands labeled with radionuclides is a novel diagnostic and therapeutic option in the management of prostate cancer.
• future: In the last decade the radioactive metals 225Actinium (t1/2=10 days) and 227Thorium . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.